Department of Surgery, Western University, London, ON, Canada.
ICES, London, ON, Canada.
Neurourol Urodyn. 2020 Nov;39(8):2401-2408. doi: 10.1002/nau.24502. Epub 2020 Sep 9.
To characterize the use of common urinary tract infections (UTI)-relevant antibiotics after an SCI and determine the risk of Clostridium difficile infection (CDI) from these antibiotics.
We used routinely collected data from Ontario (Canada) to conduct a retrospective, cohort study. We identified people >18 years of age with a traumatic SCI between April 2003 and March 2017. The primary exposure was an outpatient UTI-relevant antibiotic prescription during our observation period, and the primary outcome was evidence of a CDI. An adjusted cox proportional hazards model was used, and antibiotic exposure was modeled as a categorical, time-varying variable based on whether the patient likely had a UTI or not.
We identified 2528 people with SCI; 1642 (65%) were exposed at least once to an antibiotic of interest. The most commonly prescribed UTI-relevant antibiotic was fluoroquinolone (34%). Most patients did not have investigations for a UTI before the use of any of the different antibiotic classes. A small number of patients (5%) used chronic (>3 months) UTI-relevant antibiotics. The overall proportion of patients diagnosed with CDI was 7.4% (9.3/10 000 patient-days). The adjusted hazard ratio for CDI within 30 days was 3.5 (95% confidence interval, 1.9-6.7, p < .01) if they were exposed to a UTI-relevant antibiotic likely associated with a UTI, which was similar to the risk from UTI-relevant antibiotics which may not have been for a UTI.
The rate of CDI is high in this population and outpatient antibiotics that are commonly used for UTIs are a significant risk factor for CDI.
描述脊髓损伤(SCI)后常见尿路感染(UTI)相关抗生素的使用情况,并确定这些抗生素导致艰难梭菌感染(CDI)的风险。
我们使用安大略省(加拿大)的常规收集数据进行回顾性队列研究。我们确定了 2003 年 4 月至 2017 年 3 月期间患有创伤性 SCI 的年龄大于 18 岁的患者。主要暴露为观察期内门诊 UTI 相关抗生素处方,主要结局为 CDI 证据。采用调整后的 Cox 比例风险模型,根据患者是否可能患有 UTI,将抗生素暴露建模为分类、时变变量。
我们确定了 2528 名 SCI 患者;1642 名(65%)至少使用过一次感兴趣的抗生素。最常开的 UTI 相关抗生素是氟喹诺酮(34%)。大多数患者在使用任何不同抗生素类别之前都没有进行过 UTI 的检查。少数患者(5%)使用慢性(>3 个月)UTI 相关抗生素。诊断为 CDI 的患者比例总体为 7.4%(9.3/10000 患者日)。如果在 30 天内使用 UTI 相关抗生素(可能与 UTI 相关),则 CDI 的调整后风险比为 3.5(95%置信区间,1.9-6.7,p<0.01),这与 UTI 相关抗生素的风险相似,这些抗生素可能不是用于 UTI。
该人群中 CDI 的发生率较高,常用于治疗 UTI 的门诊抗生素是 CDI 的重要危险因素。